Boyd Steven

CIK 000170614021 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001706140

Recent Transactions

50 trades

Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2023-06-27$0.52/sh−937,404→ 731,458 total
Sale
Avalo Therapeutics, Inc.$AVTX
Common Stock
2023-06-26$0.61/sh−2,746,138→ 1,668,862 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Warrant
2023-02-07+450,000→ 450,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2023-02-07+450,000→ 4,415,000 total
Small Acquisition
Avalo Therapeutics, Inc.$AVTX
Common Stock
2023-02-03$3.95/sh+334→ 3,965,000 total
Award
TENAX THERAPEUTICS, INC.$TENX
Warrant (right to buy)
2022-05-18+4,773,269→ 4,773,269 total
Award
TENAX THERAPEUTICS, INC.$TENX
Series B Common Stock Purchase Warrants
2022-05-18+3,175,924→ 3,175,924 total
Disposition to Issuer
TENAX THERAPEUTICS, INC.$TENX
Common Stock Purchase Warrants
2022-05-18−2,360,313→ 0 total
Disposition to Issuer
TENAX THERAPEUTICS, INC.$TENX
Series C Common Stock Purchase Warrants
2022-05-18−4,607,692→ 0 total
Disposition to Issuer
TENAX THERAPEUTICS, INC.$TENX
Warrant (right to buy)
2022-05-18−4,773,269→ 0 total
Award
TENAX THERAPEUTICS, INC.$TENX
Pre-Funded Common Stock Purchase Warrants
2022-05-18+10,596,027→ 10,596,027 total
Disposition to Issuer
TENAX THERAPEUTICS, INC.$TENX
Common Stock Purchase Warrants
2022-05-18−2,072,538→ 0 total
Award
TENAX THERAPEUTICS, INC.$TENX
Series C Common Stock Purchase Warrants
2022-05-18+10,596,027→ 10,596,027 total
Disposition to Issuer
TENAX THERAPEUTICS, INC.$TENX
Series B Common Stock Purchase Warrants
2022-05-18−3,175,924→ 0 total
Award
TENAX THERAPEUTICS, INC.$TENX
Common Stock Purchase Warrants
2022-05-18+2,360,313→ 2,360,313 total
Award
TENAX THERAPEUTICS, INC.$TENX
Common Stock Purchase Warrants
2022-05-18+2,072,538→ 2,072,538 total
Award
TENAX THERAPEUTICS, INC.$TENX
Series C Common Stock Purchase Warrants
2022-05-18+4,607,692→ 4,607,692 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-03-14$0.65/sh+100,000→ 47,576,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-03-11$0.69/sh+100,000→ 47,476,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-03-10$0.70/sh+26,000→ 47,376,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-03-07$0.66/sh+325,000→ 47,350,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-03-04$0.70/sh+135,000→ 47,025,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-03-03$0.71/sh+50,000→ 46,890,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-02-25$0.79/sh+40,000→ 46,840,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-02-24$0.80/sh+100,000→ 46,800,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-02-22$0.77/sh+83,000→ 46,700,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-02-18$0.82/sh+55,000→ 46,617,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-02-17$0.81/sh+150,000→ 46,562,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-01-20$0.85/sh+12,000→ 46,412,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-01-19$0.88/sh+93,700→ 46,400,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-01-18$0.88/sh+206,300→ 46,306,300 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-01-14$0.93/sh+85,000→ 46,100,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-01-13$1.00/sh+312,700→ 46,015,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-01-12$1.04/sh+57,300→ 45,702,300 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-01-11$0.96/sh+16,003→ 45,645,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-01-10$0.99/sh+491,097→ 45,628,997 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2022-01-07$1.04/sh+137,900→ 45,137,900 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2021-09-17$2.20/sh+5,454,545→ 45,000,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2021-09-16$2.28/sh+150,000→ 39,545,455 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2021-09-15$2.26/sh+95,455→ 39,395,455 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2021-08-18$2.78/sh+20,000→ 39,300,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2021-08-16$2.75/sh+30,000→ 39,280,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2021-08-06$2.83/sh+25,000→ 39,250,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2021-08-05$2.77/sh+25,000→ 39,225,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2021-08-04$2.69/sh+100,000→ 39,200,000 total
Sale
KIORA PHARMACEUTICALS INC$KPRX
Common Stock
2021-08-02$2.40/sh−192,775→ 785,000 total
Sale
KIORA PHARMACEUTICALS INC$KPRX
Common Stock
2021-07-30$2.69/sh−68,188→ 977,775 total
Sale
KIORA PHARMACEUTICALS INC$KPRX
Common Stock
2021-07-29$3.00/sh−400,000→ 1,045,963 total
Sale
KIORA PHARMACEUTICALS INC$KPRX
Common Stock
2021-07-28$3.28/sh−375,443→ 1,445,963 total
Sale
KIORA PHARMACEUTICALS INC$KPRX
Common Stock
2021-07-27$4.59/sh−532,069→ 2,403,020 total

Recent Filings

Address

C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 22ND FLOOR

NEW YORK, NY, 10022

View on SEC.gov